The Cooper Companies Inc. (COO) exhibits 65.5% gross margins and 5.3% return on invested capital within Health Care (Ophthalmic Goods), balanced against a 13.3x enterprise multiple and 6.9% implied options volatility.
Sustained 65.5% gross profitability converts into 16.7% operating margin and 5.3% ROIC, outpacing sector cost of capital.
ROIC: 5.3% // GM: 65.5%YoY revenue trajectory of +5.1% paired with 3.78% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +5.1% // FCF YLD: 3.78%Altman Z-Score of 3.13 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.13 // F-SCORE: 8/9Trading at 30.6x trailing P/E (28.5x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 30.6x // EV/EBITDA: 13.3xOptions market prices a ±6.9% implied move with a 0.72 put/call ratio around $59.00 max pain.
IMPL MOVE: ±6.9% // P/C: 0.72Elevated industry capital intensity and customer concentration in Ophthalmic Goods require continuous execution to defend 9.2% net margins.
NET MARGIN: 9.2% // D/E: 0.22x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for COO & activate live FRED threshold breach alerts.